-
Cost-effectiveness of Chimeric Antigen Receptor (CAR) T-cell Therapy for Relapsed or Refractory Large B-cell Lymphoma (r/r LBCL): A Systematic Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Baseline Risk of Hospitalization and Mortality in High-Risk Subgroups of a Nirmatrelvir/Ritonavir Treatment-Eligible Population With Mild-to-Moderate COVID-19 in the United States: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Discontinuation Rates of Once-Weekly GLP-1 Receptor Agonists (GLP-1 RAs) in Patients With Type 2 Diabetes
Mar 10, 2025, 14:00 PM -
Role of Relative Dose Intensity in Health Economic Evaluations: A Review of National Institute for Health and Care Excellence Technology Appraisals of Treatments in Solid Tumors
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Adjuvant Chemotherapy for Soft Tissue Sarcoma Using Linked NETSARC+ (French Registry) and SNDS (French National Health Data System) Real World Data: The Deepsarc Study
Mar 10, 2025, 14:00 PM -
Can Gen-AI Assist in Translating Health Economic Data Across Formats? A Proof-of-Concept for an HEOR Translator Tool
Mar 10, 2025, 14:00 PM -
Linkage Of Patient Services and Real-world Healthcare Data: A Unique Approach to Gain Insights into Factors that Impact Medication Adherence
Mar 10, 2025, 14:00 PM -
A Cost-Effectiveness Analysis of Diagnostic Testing in Alzheimer's Disease
Mar 10, 2025, 14:00 PM -
Target Aggregate Data Adjustment Method (TADA): A Solution for Performing Transportability Analysis with Only Aggregate-Level Data in the Target Population
Mar 10, 2025, 14:00 PM -
Retrospective Real-World Study Assessing Treatment Patterns of Adult Patients with Moderate-to-Severe Psoriasis in the United States Initiating Advanced Therapies and Their Dispositions
Mar 10, 2025, 14:00 PM -
Challenges of Pre-Market Clinical Investigations of Medical Devices: A Multi-Stakeholder Perspective
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States
Mar 10, 2025, 14:00 PM -
National Respiratory Surge Forecasting With Combined Pharmacy and Public Health Data
Mar 10, 2025, 14:00 PM -
Trends in the Uptake of SGLT-2 Inhibitors in Type 2 Diabetes Mellitus With Comorbid Cardiovascular Conditions: A Longitudinal Analysis
Mar 10, 2025, 14:00 PM -
Real-World Patient Persistence and Adherence: A Comparison Of Long Acting Injectables and Oral Antipsychotics Used For The Treatment Of Schizophrenia in a Canadian Adult population
Mar 10, 2025, 14:00 PM -
Therapeutic Options for Changing the Course of Disease in Generalized Myasthenia Gravis (gMG) and Fiscal Consequences for the Canadian Governments
Mar 10, 2025, 14:00 PM -
Content Validation of the Most Bothersome Symptom - Essential Tremor Questionnaire (MBS-ET): A Cognitive Debriefing Study
Mar 10, 2025, 14:00 PM -
Improving the Face Validity and Clinical Relevance of a Cancer Epidemiology Microsimulation Model Using a Novel Advisory Group Approach
Mar 10, 2025, 14:00 PM -
Chimeric Antigen Receptor T Cell (CAR T) Therapy As Second-Line (2L) Treatment for Patients With Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): Therapy Choice and Treatment Barriers Among US Oncologists
Mar 10, 2025, 14:00 PM -
Impact of Route of Administration and HCP- or Self-Administration on Pricing of Non-Oncology Orphan Products, 2015-2024
Mar 10, 2025, 14:00 PM
